Grifols, S.a.

Nuria Hosta Mateu

Juan Ignacio Jorquera Nieto

Olga Santaeularia Lozano

The invention discloses a purified albumin solution of human origin with low prekallicrein activator (PKA) activity and stability over time characterized in that it has an antithrombin content equal to or greater than 0.03 mg/g of albumin, and a process for production thereof by the partial extraction of the antithrombin during fractionation of the human plasma.

Therapeutic human albumin solutions with low prekallikrein activator (PKA) activity and process for obtaining them

The invention discloses a purified albumin solution of human origin with low prekallicrein activator (PKA) activity and stability over time characterised in that it has an antithrombin content equal to or greater than 0.03 mg/g of albumin, and a process for production thereof by the partial extraction of the antithrombin during fractionation of the human plasma.

Growing community of inventors

Barcelona, Spain

Nuria Hosta Mateu